1. miR-182 and miR-183 Promote Cell Proliferation and Invasion by Targeting FOXO1 in Mesothelioma
   Rui Suzuki et al, 2018, Frontiers in Oncology CrossRef
2. CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
   Toshihiro Okamoto et al, 2014, PLoS ONE CrossRef
3. CD63 and GLUT-1 Overexpression Could Predict a Poor Clinical Outcome in GIST: A Study of 54 Cases with Follow-Up
   Piotr Lewitowicz et al, 2016, Gastroenterology Research and Practice CrossRef
4. Malignant Mesothelioma
   Katalin Dobra et al, 2018, Serous Effusions CrossRef
5. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling
   Yandong Li et al, 2020, Cell Death & Disease CrossRef
6. Giant malignant mesothelioma in the upper mediastinum: A case report
   SHUGUANG ZHANG et al, 2013, Oncology Letters CrossRef
7. CD9, a tetraspanin target for cancer therapy?
   Aurelio Lorico et al, 2021, Experimental Biology and Medicine CrossRef
8. Prognostic factors in malignant pleural mesothelioma
   Ben Davidson, 2015, Human Pathology CrossRef
9. Increased CD9 expression predicts favorable prognosis in human cancers: a systematic review and meta-analysis
   Hyun Min Koh et al, 2021, Cancer Cell International CrossRef
10. Prognostic value and multifaceted roles of tetraspanin CD9 in cancer
    Róbert Ondruššek et al, 2023, Frontiers in Oncology CrossRef
11. Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma
    VISHWA JEET AMATYA et al, 2016, International Journal of Oncology CrossRef
12. Prognostic Value of CD9 in Solid Tumor: A Systematic Review and Meta-Analysis
    Ping Zeng et al, 2021, Frontiers in Oncology CrossRef
13. CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?
    Carole Brosseau et al, 2018, Frontiers in Immunology CrossRef